Géraud Dautzenberg

Summary and general discussion

mocatest.org (no date). Available at: https://www.mocatest.org/ (Accessed: 31 December 2019). Mukku, S. S. R. et al. (2021) ‘Geriatric Depression and Cognitive Impairment—AnUpdate’, Indian Journal of Psychological Medicine . SAGE Publications Ltd, pp. 286–293. doi: 10.1177/0253717620981556. Nasreddine, Z. S. et al. (2005) ‘The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment’, Journal of the American Geriatrics Society , 53(4), pp. 695–699. doi: 10.1111/j.1532-5415.2005.53221.x. Nederlandse Vereniging voor Klinische Geriatrie (2014) Richtlijn ‘Diagnostiek en medicamenteuze behandeling van dementie’ . Utrecht: CBO. Available at: https://www.nvvp.net/stream/richtlijn diagnostiek-en-behandeling-van-dementie-2014. Noel-Storr, A. H. et al. (2014) ‘Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative’, Neurology , 83(4), pp. 364–373. doi: 10.1212/WNL.0000000000000621. O’Caoimh, R., Timmons, S. and Molloy, D. W. (2016) ‘Screening for mild cognitive impairment: Comparison of “MCI Specific” screening instruments’, Journal of Alzheimer’s Disease . IOS Press, 51(2), pp. 619–629. doi: 10.3233/JAD-150881. Oren, N. et al. (2014) ‘The montreal cognitive assessment in cognitively-intact elderly: A case for age adjusted cutoffs’, Journal of Alzheimer’s Disease , 43(1), pp. 19–22. doi: 10.3233/JAD-140774. Pendlebury, S. T. et al. (2015) ‘Routine cognitive screening in older patients admitted to acute medicine: Abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE’, Age and Ageing . Oxford University Press, 44(6), pp. 1000–1005. doi: 10.1093/ageing/afv134. Prince, M., Bryce, R. and Ferri, C. (2011) World Alzheimer Report 2011: The Benefits of Early Diagnosis and Intervention , World Alzheimer Report 2015 . Available at: http://www.alz.co.uk/research/ WorldAlzheimerReport2011.pdf. Prince, M. and Comas-Herrera, A. (2016) ‘World Alzheimer Report 2016’. Available at: www.alz.co.uk. Ramírez, L. R. B. et al. (2014) ‘Validez de la escala de evaluación cognitiva de montreal (MoCA) para determinar deterioro cognitivo en pacientes con esquizofrenia’, Salud Mental . Instituto Nacional de Psiquiatria Ramon de la Fuente, 37(6), pp. 517–522. doi: 10.17711/sm.0185-3325.2014.062. Van Rheenen, T. E. et al. (2017) ‘Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum’, Psychological Medicine . Cambridge University Press, 47(10), pp. 1848–1864. doi: 10.1017/S0033291717000307. Van Rheenen, T. E. et al. (2020) ‘Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence’, Bipolar Disorders . Blackwell Publishing Inc., pp. 13–27. doi: 10.1111/bdi.12821. Riddle, M. et al. (2017) ‘Longitudinal cognitive outcomes of clinical phenotypes of late-life depression HHS Public Access’, Am J Geriatr Psychiatry , 25(10), pp. 1123–1134. doi: 10.1016/j.jagp.2017.03.016. Rossetti, H. C. et al. (2011) ‘Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample’, Neurology , 77(13), pp. 1272–1275. doi: 10.1212/WNL.0b013e318230208a. Rund, B. R. et al. (2016) ‘Neurocognition and Duration of Psychosis: A 10-year Follow-up of First Episode Patients’, Schizophrenia Bulletin . Oxford University Press, 42(1), pp. 87–95. doi: 10.1093/ schbul/sbv083.

7

191